BiotechTube
Home/Sterna Biologicals & KG/Thomas Klaue
TK

Thomas Klaue

Chief Financial Officer (consulting)

Sterna Biologicals & KG

Therapeutic Areas

AsthmaUlcerative ColitisChronic Obstructive Pulmonary Disease (COPD)Atopic Dermatitis

Sterna Biologicals & KG Pipeline

DrugIndicationPhase
hgd40Chronic Inflammatory Diseases (e.g., Asthma, Atopic Dermatitis, Ulcerative Colitis, COPD)Phase 2

Leadership Team at Sterna Biologicals & KG

KP
Konstantin Petropoulos
Chief Executive Officer/Managing Director
View full Sterna Biologicals & KG profile